Please use this identifier to cite or link to this item:
|Title:||The rise of carbapenem resistance in Europe : just the tip of the iceberg?|
Monnet, Dominique L.
Heuer, Ole E.
|Keywords:||Anti-infective agents industry -- Europe|
|Publisher:||BioMed Central Ltd.|
|Citation:||Magiorakos, A. P., Suetens, C., Monnet, D. L., Gagliotti, C., & Heuer, O. E. (2013). The rise of carbapenem resistance in Europe: just the tip of the iceberg?. Antimicrobial Resistance and Infection Control, 2(1), 6.|
|Abstract:||The European Antimicrobial Resistance Surveillance Network (EARS-Net) collects data on carbapenem resistance from invasive bacterial infections. Increasing percentages of carbapenem resistance in K. pneumoniae isolates were reported from progressively more countries in Europe between 2005 and 2010. A trend analysis showed increasing trends for Greece, Cyprus, Hungary and Italy (p < 0.01). EARS-Net collects data on invasive bacterial isolates, which likely correspond to a fraction of the total number of infections. Increasing reports of community cases suggest that dissemination of carbapenem-resistant K. pneumoniae has penetrated into the community. Good surveillance and infection control measures are urgently needed to contain this spread.|
|Appears in Collections:||Scholarly Works - ERCMedGen|
Files in This Item:
|The_rise_of_carbapenem_resistance_in_Europe.pdf||272.59 kB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.